Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A study investigating the incidence of total knee replacement subsequent to intra-articular injections of Ampion versus saline (a long-term follow-up study to a randomized controlled trial AP007)

Trial Profile

A study investigating the incidence of total knee replacement subsequent to intra-articular injections of Ampion versus saline (a long-term follow-up study to a randomized controlled trial AP007)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 05 Jun 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs DMI 9523 (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Ampio Pharmaceuticals
  • Most Recent Events

    • 05 Jun 2018 According to an Ampio media release, results from this study were published in the Patient Safety in Surgery, a peer-reviewed journal.
    • 29 May 2018 New trial record
    • 22 May 2018 According to the Ampio Pharmaceuticals media release, this study was accepted for publication in the peer-reviewed journal Patient Safety in Surgery.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top